Exercise slashes risk of death in patients with colon cancer
Exercise slashes the risk of death in patients with colon cancer by more than a third, a trial has found.
Physical activity could also prevent the disease from coming back, as well as lifting mood, reducing fatigue and boosting strength, according to researchers.
Colon cancer develops in the part of the large intestine known as the colon, part of the large bowel, which also comprises the rectum and anus.
It can sometimes be referred to as bowel cancer or colorectal cancer.
Cancer Research UK estimates about 31,800 people every year in the UK are diagnosed with the disease, with around 9,500 deaths.
The CO21 Challenge trial, led by researchers in Northern Ireland and Canada, involved 889 people with colon cancer from six countries, including the UK.
All patients had had surgery and chemotherapy for their cancer and were deemed well enough to exercise, but were not meeting recommended physical activity levels.
Around half were given a three-year tailored exercise programme, which included the likes of brisk walking, circuit classes, cycling, or swimming.
The plan included in-person coaching sessions for the first six months, as well as regular meetings with a physical activity consultant.
The other group were offered materials that promoted exercise and nutrition.
The study found that after five years, the risk of dying, relapse or developing a new cancer was 28% lower in the group with a tailored exercise plan.
After eight years, patients in the physical activity group had a 37% lower risk of death.
Professor Vicky Coyle, UK lead researcher for the trial and clinical professor at Queen's University Belfast, said: 'During the trial, we supported people to reach their weekly exercise target in a way that worked for them.
'This could be a brisk walk for around 40 minutes every day, but some patients were also doing circuit classes, cycling, swimming, and many other activities.
'Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer.
'We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate.'
Dr Joe Henson, associate professor in lifestyle medicine at the University of Leicester, said: 'Leading the exercise sessions in Leicester, I saw first-hand that this reduced fatigue, lifted people's mood, and boosted their physical strength.
'We know that physical activity regulates several key biological processes that could explain these results, and further research will help us uncover why exercise is having such a positive impact.'
The findings, published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO), could 'transform clinical practice', according to experts.
Caroline Geraghty, senior specialist information nurse at Cancer Research UK, which part-funded the CO21 Challenge through Stand Up To Cancer, said: 'Being active has many benefits, and this study shows that exercise doesn't only improve well-being – it can also boost people's chances of surviving colon cancer.
'Everyone recovering from cancer should have access to tailored support to help them live longer, better lives.
'This trial has the potential to transform clinical practice, but only if health services have the necessary funding and staff to make it a reality for patients.
'It's important to remember that every cancer journey is different – starting new activities after treatment can feel overwhelming, and it may not be the right option for everyone. Take things at your own pace and speak to your doctor to discuss what is safe for you.'
Professor Peter Johnson, NHS national clinical director for cancer, said: 'These exciting findings add to the growing evidence of the benefits of physical activity for people affected by cancer, not just in helping them be fitter for treatment and boosting their immediate recovery, but reducing the risk of the disease coming back.
'This is why we've asked cancer alliances across the country to look at ways to encourage and support patients to do physical activity and ensure every healthcare professional they see can help them be in the best possible place – both physically and mentally – before, during and after treatment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Your ‘five-a-day' now includes chocolate... and wine
For those people who find cramming in five portions of fruit and veg a day about as appealing as limp lettuce, scientists have good news: now you can count red wine and dark chocolate. A new five-a-day diet including tea, apples, oranges and berries – all foods rich in chemicals called flavonoids - will help people to live longer, a study has found. Flavonoids have a range of benefits, including lowering high blood pressure and dampening inflammation. Scientists have long known them to be good for health, but the new study is the first to investigate the benefits of a diversity of different flavonoids, not just the quantity. There are five main groups of flavonoids covering dozens of unique chemicals, but one main tranche is anthocyanins, found in abundance in grapes and red wine. Tea is rich in flavan-3-ols, another flavonoid, while orange juice is full of flavonones, and kale has high levels of flavones. Some foods, such as apples and tea, contain several flavonoids of different categories, while some only contain one. Scientists looked at the benefits of a diversity of these chemicals in a person's diet by assessing almost 125,000 Britons enrolled in the UK Biobank. Specific food and drink intake was compared to health outcomes over a decade of follow-up by scientists at Queen's University Belfast. Participants who consumed at least 1,000 milligrams of flavonoids a day were a fifth less likely to die during the study period, data showed, confirming that flavonoid quantity was linked to better health. Further analysis on the impact of flavonoid diversity found people in the lowest 20 per cent of the study consumed on average just one food product which was rich in flavonoids a day. Those in the top 20 per cent who ate five portions of flavonoid-rich foods a day were found to have a 16 per cent lower risk of death during the study period. Prof Aedín Cassidy, study author and chair in nutrition and preventive medicine at Queen's University Belfast, told The Telegraph: 'A flavonoid 'five-a-day' has the potential to reduce mortality. 'The data suggest that there is a benefit to consuming a wide range of flavonoids beyond that of simply consuming a high quantity as different flavonoids work in different ways, some improve blood pressure, others help with cholesterol levels and decrease inflammation. 'So having a variety of flavonoid-rich foods is important – eg one apple, a handful of berries, two cups of tea, and one orange. Other rich sources are onions, red wine, grapes, plums, and red cabbage.' People who hit their flavonoid five-a-day were also found to be 10 per cent less at risk of cardiovascular disease, when accounting for factors such as sex, education, BMI, profession, income, alcohol and smoking habits, prior medical history and other aspects of diet. The cancer risk was also 20 per cent lower for five-a-dayers compared to those who ate just one of their five-a-day, the study found. Risk of respiratory conditions was eight per cent lower, data showed, and there was no link for neurodegenerative conditions. 'Our findings highlight the importance of consuming a diverse range of flavonoids for the management of chronic disease risk, which, from a public health perspective, provides support for consuming a variety of flavonoid-rich foods such as green and/or black tea, berries, apples, oranges and grapes,' said the study authors in their paper. 'The collective actions of multiple flavonoids appear to lead to greater health protection compared with single subclasses or compounds. 'We found that consuming both a higher quantity and wider diversity of dietary flavonoids appears better for longer-term health than higher intakes of either component alone.' The study has been published in Nature Food. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Medscape
8 hours ago
- Medscape
UK Cancer Deaths Drop 22% in 50 Years Despite Rising Cases
Cancer death rates in the UK have fallen by 22% over the past 50 years. However, diagnoses have risen by almost half, according to a new analysis by Cancer Research UK (CRUK). The Cancer in the UK Report 2025 provides the first 50 years of UK-wide data on cancer mortality and cases. Death rates fell from around 328 per 100,000 people in 1973 to around 252 per 100,000 in 2023. CRUK described the findings as 'profound'. The charity said improvements in diagnosis, treatment, and smoking reduction had helped drive the decline. People today are twice as likely to survive their disease for at least 10 years compared to 50 years ago. Survival rates improved from one in four people in the early 1970s to one in two today. Rising Incidence Despite Progress Cancer incidence rates increased sharply by 47% during the same period. Cases rose from around 413 to 607 per 100,000 people. However, the charity noted that because of the UK's growing and ageing population, actual numbers continue to rise. Nearly 1100 new cases are diagnosed daily, with more than 460 deaths each day. This occurs despite significant progress in prevention, detection, diagnosis, and treatment. CRUK called on the government to ensure that its upcoming National Cancer Plan for England is 'ambitious and fully funded'. Early Diagnosis Rates Stagnant Research into improving screening programmes, tests, and drugs helped reduce death rates. Policy action on smoking reduced rates for cancers with poor survival outcomes. Lung cancer mortality rates decreased from 80.9 per 100,000 people in 1971-1973 to 49.8 in 2021-2023. Bowel cancer rates fell from 48.0 to 26.3, whilst breast cancer dropped from 30.7 to 16.9. However, pancreatic cancer rates remained stable at around 15 per 100,000 people. Some cancers showed increases, including prostate cancer from 13.3 to 18.3 and oesophageal cancer from 9.2 to 12.0. Just over half of cancers (54%) were diagnosed at an early stage in England, the report found. This proportion has not changed for almost a decade. Around half of all new cancer diagnoses occur in people aged 70 and over. However, incidence rates are rising fastest in younger people, with a 23% increase in people aged 20 to 49 since the early 1990s. Screening Programmes Save Lives Three cancer screening programmes save around 5000 lives every year across the UK, according to CRUK. Smoking remains the biggest cause of cancer in the UK. It accounts for around a fifth of all cancer deaths each year. Around one in 20 UK cancer deaths are now linked to being overweight or obese. Michelle Mitchell, CRUK's chief executive, welcomed the reduced death rates and doubled survival rates. However, she stressed that too many cases are diagnosed at a late stage. "If we want to change that, we need bold action from the UK government," Mitchell said. Professor Peter Johnson, NHS national clinical director for cancer, highlighted recent innovations. These include lung cancer screening in car parks and AI technology to spot skin cancer. Mitchell urged that the upcoming National Cancer Plan for England must improve survival and transform services. She said the plan "could save countless lives across England and ensure people affected by cancer live longer, better lives". CRUK has also published devolved nation summaries of its findings for Scotland, Wales, and Northern Ireland.
Epoch Times
11 hours ago
- Epoch Times
Cancer Death Rates Down More Than 20 Percent in Last 50 Years but Cases Rising: Report
Cancer death rates have fallen by more than a fifth in the last 50 years but cases are rising, according to a new analysis. A report from Cancer Research UK found people are now more likely to get cancer than decades ago, but are less likely to die from the disease. Figures show that the rate of people dying from cancer in the UK has fallen by around 22 percent since the early 1970s, but the rate of people being diagnosed with the disease has risen by almost half. In 1973, some 328 per 100,000 people died from cancer, dropping to around 252 per 100,000 in 2023, driven by improvements in areas such as diagnosis and better treatment, as well as action to cut smoking. The study said: 'Survival for all cancers combined in England and Wales has doubled since the early 1970s, but progress has slowed over the last 10 years and remains lower than other comparable countries. 'Survival increased three to five times faster in previous decades, compared with the improvement since 2010.' Related Stories 5/30/2025 5/24/2025 Cancer Research UK warned that, despite improvement in overall survival, many more people are being diagnosed with cancer compared with 50 years ago. Incidence rates have risen sharply by almost half (47 percent) across Great Britain over this period, from around 413 cases per 100,000 people to around 607 cases per 100,000 people. The report listed the preventable causes of cancer, saying smoking remains the biggest cause of cancer, while obesity is linked to 13 different types of the disease. Other risks include not using sunscreen or failing to cover up in the sun, sunbeds, alcohol, lack of exercise, and diets high in processed meat. A general view of staff on a NHS hospital ward at Ealing Hospital in London, on Jan. 18, 2023. Jeff Moore/PA Media The report pointed out that around half of all new cancer diagnoses are in people aged 70 and over, but incidence rates are currently rising fastest in younger people. It said: 'In the UK, cancer incidence rates have increased by 23% in people aged 20 to 49 since the early 1990s. 'However, population growth is concentrated in older age groups, so in terms of patient numbers, the biggest increase in cancer cases has been in older people.' The study also found that, on average, just over half of cancers are diagnosed at an early stage in England (54 percent), and this proportion has not changed for almost a decade. Michelle Mitchell, Cancer Research UK's chief executive, said: 'It's fantastic to see that thanks to research, cancer death rates have drastically reduced over the last 50 years, and survival has doubled. 'However, there's more that can be done. This report highlights that over 460 people die from cancer every single day in the UK, and too many cases are diagnosed at a late stage. 'If we want to change that, we need bold action from the UK government. 'The upcoming National Cancer Plan for England must improve cancer survival, and transform cancer services. 'If this plan is done right, it could save countless lives across England and ensure people affected by cancer live longer, better lives.' Cancer Research UK is calling for commitments such as the national rollout of a targeted lung cancer screening programme, quicker access to diagnostic tests for all patients, better access to GPs for speedy diagnosis, and action to improve cancer waiting times. Its new study is the first ever to include 50 years of cancer death and incidence data for the UK. Elsewhere, MPs and members of the House of Lords have urged the government to prioritise faster diagnosis of less survivable cancers, which are those that develop in the brain, pancreas, liver, lung, oesophagus, and stomach. A new report from the All-Party Parliamentary Group (APPG) on Less Survivable Cancers claims these cancers claim 67,000 lives a year, around 42 percent of cancer deaths. Doubling diagnoses rates in these areas could save an additional 7,500 lives a year, it said. Paulette Hamilton, chairwoman of the APPG on Less Survivable Cancers, said this is a 'crucial moment for transforming patient outcomes and accelerating survival rates for the less survivable cancers.' 'We're on the brink of research breakthroughs and in the midst of developing potentially game-changing government health reforms,' she added. 'In this backdrop, achieving faster diagnosis for these devastating cancers is finally within reach.' Professor Peter Johnson, NHS national clinical director for cancer, said: 'The NHS is seeing and treating record numbers of people for cancer, with more people diagnosed at an earlier stage than ever before, and survival rates in England at an all-time high. 'We have developed world-leading programmes, including lung cancer screening in convenient locations such as car parks and using AI to spot skin cancer, making it easier than ever before to get checked. 'The latest data shows that more than three quarters of people received the all-clear or a definitive cancer diagnosis within four weeks of an NHS urgent cancer referral.'
